share_log

Credit Suisse Maintains Underperform on Clover Health Investments, Lowers Price Target to $1.25

Credit Suisse Maintains Underperform on Clover Health Investments, Lowers Price Target to $1.25

瑞士信贷维持Clover Health Investments的表现不佳,将目标价下调至1.25美元
Benzinga ·  2023/03/06 07:31

Credit Suisse analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Underperform and lowers the price target from $2.5 to $1.25.

瑞士信贷分析师乔纳森·杨维持Clover Health Investments(纳斯达克股票代码:CLOV)的表现不佳,并将目标股价从2.5美元下调至1.25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发